Horizon Capital Invests in Viseven, Leading Global Pharma and Life Sciences MarTech Provider
Posted:
Horizon Capital, a U.S. private equity firm investing primarily in fast-growing tech and export-oriented businesses in Ukraine, announced an investment in Viseven, a leading global marketing tech provider servicing the pharma and life sciences industry. This transaction marks the third investment from its latest fund, Horizon Capital Growth Fund IV (HCGF IV), which reached $328 million at its most recent closing held in December 2023.
Cardiovascular disease remains one of the leading causes of illness and death worldwide, placing significant pressure on healthcare systems and highlighting the importance of early diagnosis and timely intervention. As digital health technologies continue to evolve, wearable devices and artificial…
Behind every successful healthcare system is a supply chain that ensures medicines, medical devices and essential equipment reach the right place at the right time. While often operating behind the scenes, healthcare logistics has become one of the most important…
Attendees
Sponsors and Exhibitors
Contact us